Table 4. Laboratory analyses of dead patients in the last 24 hours of the death.
| Laboratory analyses | |
|---|---|
| Complete blood count | |
| Neutrophil count, × 109/L | 12.9 (11.3–26.0) |
| Neutrophil count >6.3 × 109/L | 19/19 (100) |
| Lymphocyte count, × 109/L | 0.5 (0.4–1.3) |
| Lymphocyte count <1.0 × 109/L | 14/19 (73.7) |
| Monocyte count, × 109/L | 0.4 (0.3–0.8) |
| Platelet count, × 109/L | 77 (62.0–147.0) |
| Platelet count <100 × 109/L | 12/19 (63.2) |
| Neutrophil-to-lymphocyte ratio | 19.6 (17.0–33.0) |
| Neutrophil-to-lymphocyte ratio >5 | 19/19 (100) |
| Platelet-to-lymphocyte ratio | 77.0 (62.0–147.0) |
| Platelet-to-lymphocyte ratio >200 | 7/19 (36.8) |
| Systemic immune-inflammation index | 1861.8 (950.8–3881.8) |
| Systemic immune-inflammation index >500 | 74/19 (100) |
| Blood biochemical analysis | |
| C-reactive protein level, U/L | 84.9 (73.5–186.6) |
| C-reactive protein level >10U/L | 13/13 (100) |
| Alanine aminotransferase, U/L | 30.5 (22.0–102.5) |
| Alanine aminotransferase >40U/L | 8/20 (40.0) |
| Aspartate aminotransferase, U/L | 74.5 (35.5–184.0) |
| Aspartate aminotransferase >40U/L | 14/20 (70.0) |
| Albumin, g/L | 31 (28.9–32.6) |
| Albumin <40g/L | 18/20 (90.0) |
| Potassium, mmol/L | 4.3 (3.9–4.7) |
| Sodium, mmol/L | 147.0 (143.0–156.0) |
| Blood urea nitrogen, mmol/L | 18.4 (8.5–33.5) |
| Blood urea nitrogen >8.8mmol/L | 17/20 (85.0) |
| Creatinine, μmol/L | 123 (87.5–361.5) |
| Creatinine >133μmol/L | 9/20 (45.0) |
| Creatine kinase, U/L | 258.0 (135.0–535.0) |
| Creatine kinase >200 U/L | 15/21 (71.4) |
| Myoglobin, μg/L | 342.5 (136.2–1000.0) |
| Myoglobin >110μg/L | 13/15 (86.7) |
| Lactate dehydrogenase, U/L | 784 (484.0–1,216.0) |
| Lactate dehydrogenase >250 U/L | 19/19 (100) |
| Creatine kinase-MB, ng/ml | 4.1 (2.7–7.0) |
| Creatine kinase-MB >5ng/ml | 5/15 (33.3) |
| NT-pro B-type natriuretic peptide, pg/ml | 3046.5 (1423.0–14262.0) |
| NT-pro B-type natriuretic peptide >1800 pg/ml | 10/14 (71.4) |
| Cardiac troponin T, pg/ml | 0.7 (0.1–8.7) |
| Cardiac troponin T >0.04 | 10/15 (66.7) |
| Procalcitonin, ng/ml | 1.1 (0.4–6.4) |
| Procalcitonin >0.1 ng/ml | 14/16 (87.5) |
| Prothrombin time, s | 17.2 (14.3–26.8) |
| Prothrombin time >12.1s | 13/13 (100) |
| Activated partial thromboplastin time, s | 32.8 (31.3–37.2) |
| D-dimer, mg/L | 42.7 (9.9–74.0) |
| D-dimer >0.55mg/L | 13/13 (100) |
| Interleukin-6, pg/ml | 258.0 (105.6–262.4) |
| Interleukin-6 >10pg/ml | 11 (100) |
| Arterial gas | |
| PH | 7.3 (7.0–7.4) |
| PH <7.35 | 9/17 (52.9%) |
| PH >7.45 | 4/17 (23.5%) |
| pO2 | 47 (40–61) |
| pO2 <60 mmHg | 12/17 (70.6) |
| pCO2 | 32.0 (28.0–42.0) |
| pCO2 <35 mmHg | 9/17 (52.9) |
| pCO2 >50 mmHg | 4/17 (23.5) |
Data are presented as median (IQR), n/N (%), where N represents the total number of patients with COVID-19 with available data